![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ipso Ventures | LSE:IPS | London | Ordinary Share | GB00B1GDWB47 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.425 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
15/9/2011 19:20 | The milestone payment recievable by Therakind and all the other commercial terms of Therakind's agreement with Viropharma are subject to commercial confidentiality as is common in the pharmaceutical industry. ok... | ![]() tomboyb | |
15/9/2011 19:08 | Well I had a very swift reply from the company when I asked about this milestone payment....reply below: The milestone payment recievable by Therakind and all the other commercial terms of Therakind's agreement with Viropharma are subject to commercial confidentiality as is common in the pharmaceutical industry. I am sorry that i cannot therefore provide this information to you or the market as whole. Nick Rodgers | ![]() 27macca | |
15/9/2011 19:05 | "Our paediatric healthcare business, Therakind Limited, secured a further £350,000 of funding from third party investors in April 2009 at a price that increased the value of its original investment by 61%. Therakind continues to generate revenues but, more importantly, in July 2009 it secured European regulatory approval to commence the final stage of development for its first paediatric drug. A contract was also signed with a pharmaceutical manufacturer during the year to develop a second drug for the treatment of pain." Remember for a £1.4mill cap - what value now is attributed to its 36% holding in ONE of its investments. PUMA gives patent-like protection for 10 years 9as far as i have read). £10mill was given to Auralis Limited. Buccluom was a joint venture with therakind. So the significant sum is yet to be deciphered considering a majority of its stake was sold off. They still have a stake and Royalty fees but those are certainly questions for management. A contract was also signed with a pharmaceutical manufacturer during the year to develop a second drug for the treatment of pain." This is only 1 of many IPSO companies. | ![]() tomboyb | |
15/9/2011 19:03 | Abbreviated accounts posted for Therakind - £500k loss 2011 - but 300% increase in co value - perhaps from significant payment or the fund raise.... who knows - its fingers crossed time i guess .... good luck all | ![]() electrick | |
15/9/2011 18:50 | Macca - what value was the significant initial payment? | ![]() electrick | |
15/9/2011 18:49 | When will the amount of the "milestone payment" paid to therakind be disclosed as this is key info. | ![]() 27macca | |
15/9/2011 18:45 | lol!! I do.... Was trying to engage a message board to solicit assistance... calls in to the company and looking at the firms and the product providing revenues... Do you hold a few TOm? | ![]() electrick | |
15/9/2011 18:44 | Put it simply electrik - dyor. | ![]() tomboyb | |
15/9/2011 18:42 | guess not Top..... so I was correct in that no sells for 3.5 or over today and guessing that will continue.. I like the company ethos and its portfolio... today brought it to attention - shame no one seems to want to share / or know anything about it!!! well other than Whooosh... 10p tomorrow etc etc Regards | ![]() electrick | |
15/9/2011 18:38 | Yes ...You bought the wrong stock!!!!!!!!!!!!!!! | topinfo | |
15/9/2011 18:37 | typo!... but do you have any answers??? | ![]() electrick | |
15/9/2011 18:35 | IPSA dont get anything you fool, they are selling wind turbines. Did you buy IPSA thinking you were buying IPS...lol electrick - 15 Sep'11 - 18:23 - 258 of 259 So if no one else can help........ help your self :o) this was RNS'd on 25th June (old news!) BUT can anyone tell me the value of IPSA's share of the "significant initial upfront payment " Given that revenues in the 2011 accounts were only up£80k....... Milestone payment not described as significant,,,, Help me here.. still digging :o) | topinfo | |
15/9/2011 18:34 | - Approval Offers Convenient Alternative to Treat Seizures in Children and Adolescents - - First Ever Product Approved through European Commission's Centralized Pediatric Use Marketing Authorization (PUMA) - EXTON, Pa., Sept. 6, 2011 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that the European Commission has granted a Centralized Pediatric Use Marketing Authorization (PUMA) for Buccolam® (midazolam, oromucosal solution), for treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents, from 3 months to less than 18 years of age. This action by the European Commission represents the first product approval through the centralized PUMA procedure since its inception. In connection with the approval of Buccolam, ViroPharma will make an additional payment of 10 million Pounds Sterling (approximately $16.3 million based on the August 31, 2011 exchange rate) to the former owners of Auralis Limited. | ![]() 27macca | |
15/9/2011 18:31 | Sorry if already posted, IPS! Buccolam now licensed for children in an EU first Fri, 09/09/2011 - 14:04 By News team Buccolam, an oromucosal solution of midazolam, is now licensed for children aged between three months and 18 years of age for the treatment of severe convulsions and epileptic seizures, after becoming the first medicine to be granted a paediatric-use marketing authorisation (PUMA). The licence was granted by the European Commission on 5 September 2011 and the product, from ViroPharma SPRL, is expected to be available in the UK from early October 2011. | ![]() 27macca | |
15/9/2011 18:23 | So if no one else can help........ help your self :o) this was RNS'd on 25th June (old news!) BUT can anyone tell me the value of IPSO's share of the "significant initial upfront payment " Given that revenues in the 2011 accounts were only up£80k....... Milestone payment not described as significant,,,, Help me here.. still digging :o) | ![]() electrick | |
15/9/2011 17:09 | and oxb did not come out with the news we got today | ![]() falia | |
15/9/2011 17:08 | but 10p definitely | ![]() falia | |
15/9/2011 17:08 | your right king this is not worth 85p | ![]() falia | |
15/9/2011 17:05 | Falia Is that how you pump and dump a stock, most stocks on the market especially bios were once 10-50 times their current price, it dont mean they are cheap. Oxb is 6p and was once a huge price, dont change a thing. | ![]() kinghorm23 | |
15/9/2011 17:00 | these were at 85p | ![]() falia | |
15/9/2011 16:51 | just cant see why company did not announce this earlier in the week, anyway good luck to all those that holds we should get good press in the morning | ![]() falia | |
15/9/2011 16:45 | Major shareholders updated and will update daily chart ---- | ![]() tomboyb | |
15/9/2011 16:41 | what are you thinking when reading this link (last paragraph)? 1. "wow lots of money possible here" or 2. "todays news on IPS is good for all those that suffer from epilepsy" hopefully a bit of 2 | stoney4th |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions